Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,340 JPY | +0.12% | +0.09% | +7.96% |
05-01 | JSR Swings Into the Red in Fiscal 2024 | MT |
04-18 | JSR's Buyer Completes Tender Offer | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
Weaknesses
- With an expected P/E ratio at 63.42 and 18.39 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+7.96% | 5.71B | B+ | ||
+14.43% | 64.32B | A- | ||
-3.80% | 45.95B | A- | ||
+13.69% | 39.61B | B+ | ||
+20.84% | 25.74B | A- | ||
+8.66% | 18.75B | C+ | ||
+1.20% | 17.23B | B+ | ||
-21.03% | 15.86B | A- | ||
+0.81% | 15.03B | B+ | ||
-12.61% | 13.99B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4185 Stock
- Ratings JSR Corporation